Exton-based Biopharmaceutical Releases Findings from Ongoing Preclinical COVID-19 Research

Retrieved on: 2021-02-05 21:33:45

Tags for this article:

Click the tags to see associated articles and topics

Exton-based Biopharmaceutical Releases Findings from Ongoing Preclinical COVID-19 Research. View article details on hiswai:

Excerpt

(Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody ...

Article found on: www.mychesco.com